Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
OVID · Jun 30, 2025
Ovid Therapeutics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-25-040008General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-76.12% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
3611.24% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-80.88% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
103.08% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
19.44% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20255/6 normalizedLevel 3Jun 30, 20255/6 normalizedLevel 3Sep 30, 20255/6 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- -7907.69%
- Current
- -76.12%
- Delta
- 7831.58%
- Previous
- -12.16%
- Current
- 3611.24%
- Delta
- 3623.40%
- Previous
- -9653.85%
- Current
- -80.88%
- Delta
- 9572.96%
- Previous
- 5122.31%
- Current
- 103.08%
- Delta
- -5019.23%
- Previous
- 987.69%
- Current
- 19.44%
- Delta
- -968.26%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · OVID Fundamental State →Has State · Ovid Therapeutics Inc. →Transitioned To · OVID Fundamental State →Transitioned To · OVID CASH_GENERATION_INCREASED →Transitioned To · OVID GROWTH_INCREASED →Transitioned To · OVID PROFITABILITY_INCREASED →Transitioned To · OVID R_AND_D_INTENSITY_DECREASED →Transitioned To · OVID SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.